Animal models for human Metapneumovirus (HMPV) infections

Veterinary Research

Volumn 38, Issue 1, 2007, Pages 117-126

  Schildgen, Oliver ^a   Simon, Arne ^b   Williams, John ^c  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Animal models; Human metapneumovirus; Respiratory viruses

Indexed keywords

ANTIVIRUS AGENT; GLUCOCORTICOID; MONOCLONAL ANTIBODY; PALIVIZUMAB; RIBAVIRIN;

ADAPTIVE IMMUNITY; ANIMAL MODEL; CHIMPANZEE; EXPERIMENTAL ANIMAL; FERRET; HAMSTER; HUMAN METAPNEUMOVIRUS; IMMUNE RESPONSE; INNATE IMMUNITY; MEDICAL RESEARCH; NONHUMAN; PATHOGENICITY; PRIMATE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY VIRUS; REVIEW; VIRUS CELL INTERACTION; VIRUS INFECTION; ANIMAL; DISEASE MODEL; HUMAN; METAPNEUMOVIRUS; PHYSIOLOGY; VIROLOGY;

ANIMALIA; CRICETINAE; HUMAN METAPNEUMOVIRUS; MUS; MUSTELA; PARAMYXOVIRIDAE; PRIMATES; SIGMODON;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; METAPNEUMOVIRUS; PARAMYXOVIRIDAE INFECTIONS;

EID: 33847274166     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1051/vetres:2006051     Document Type: Review

References (27)

1. Alvarez R., Harrod K.S., ShiehW.J., Zaki S., Tripp R.A., Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies, J. Virol. (2004) 78:14003-14011.
2. Alvarez R., Tripp R.A., The immune response to human metapneumovirus is associated with aberrant immunity and impaired virus clearance in BALB/c mice, J. Virol. (2005) 79:5971-5978.
3. Clyde W.A. Jr., Experimental models for study of common respiratory viruses, Environ. Health Perspect. (1980) 35:107-112.
4. Darniot M., Petrella T., Aho S., Pothier P., Manoha C., Immune response and alteration of pulmonary function after primary human metapneumovirus (HMPV) infection of BALB/c mice, Vaccine (2005) 23:4473-4480.
5. Guerrero-Plata A., Baron S., Poast J.S., Adegboyega P.A., Casola A., Garofalo R.P., Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections, J. Virol. (2005) 79:10190-10199.
6. Hamelin M.E., Yim K., Kuhn K.H., Cragin R.P., Boukhvalova M., Blanco J.C., Prince G.A., Boivin G., Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats, J. Virol. (2005) 79:8894-8903.
7. Hamelin M.E., Prince G.A., Gomez A.M., Kinkead R., Boivin G., Human metapneumovirus infection induces long-term pulmonary inflammation associated with airway obstruction and hyperresponsiveness in mice, J. Infect. Dis. (2006) 193:1634-1642.
8. Hamelin M.E., Prince G.A., Boivin G., Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection, Antimicrob. Agents Chemother. (2006) 50:774-777.
9. Herd K.A., Mahalingam S., Mackay I.M., Nissen M., Sloots T.P., Tindle R.W., Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice, J. Virol. (2006) 80:2034-2044.
10. Kuiken T., van den Hoogen B.G., van Riel D.A., Laman J.D., van Amerongen G., Sprong L., Fouchier R.A., Osterhaus A.D., Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract, Am. J. Pathol. (2004) 164:1893-1900.
11. Laham F.R., Israele V., Casellas J.M., Garcia A.M., Lac Prugent C.M., Hoffman S.J., Hauer D., Thumar B., Name M.I., Pascual A., Taratutto N., Ishida M.T., Balduzzi M., Maccarone M., Jackli S., Passarino R., Gaivironsky R.A., Karron R.A., Polack N.R., Polack F.P., Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy, J. Infect. Dis. (2004) 189:2047-2056.
12. MacPhail M., Schickli J.H., Tang R.S., Kaur J., Robinson C., Fouchier R.A., Osterhaus A.D., Spaete R.R., Haller A.A., Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (HMPV) and implications for HMPV vaccine design, J. Gen. Virol. (2004) 85:1655-1663.
13. Peiris J.S., Tang W.H., Chan K.H., Khong P.L., Guan Y., Lau Y.L., Chiu S.S., Children with respiratory disease associated with metapneumovirus in Hong Kong, Emerg. Infect. Dis. (2003) 9:628-633.
14. Prince G.A., Hemming V.G., Horswood R.L., Chanock R.M., Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat, Virus Res. (1985) 3:193-206.
15. Prince G.A., Horswood R.L., Chanock R.M., Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats, J. Virol. (1985) 55:517-520.
16. Saez-Llorens X., Castano E., Null D., Steichen J., Sanchez P.J., Ramilo O., Top F.H. Jr., Connor E., Safety and pharmacokinetics of an intramuscular humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia, The MEDI-493 Study Group, Pediatr. Infect. Dis. J. (1998) 17:787-791.
17. Sami I.R., Piazza F.M., Johnson S.A., Darnell M.E., Ottolini M.G., Hemming V.G., Prince G.A., Systemic immunoprophylaxis of nasal respiratory syncytial virus infection in cotton rats, J. Infect. Dis. (1995) 171:440-443.
18. Skiadopoulos M.H., Biacchesi S., Buchholz U.J., Riggs J.M., Surman S.R., Amaro-Carambot E., McAuliffe J.M., Elkins W.R., St. ClaireM., Collins P.L., Murphy B.R., The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness, J. Virol. (2004) 78:6927-6937.
19. Spann K.M., Tran K.C., Chi B., Rabin R.L., Collins P.L., Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages, J. Virol. (2004) 78:4363-4369.
20. Van den Hoogen B.G., de Jong J.C., Groen J., Kuiken T., de Groot R., Fouchier R.A., Osterhaus A.D., A newly discovered human pneumovirus isolated from young children with respiratory tract disease, Nat. Med. (2001) 7:719-724.
21. Vicente D., Montes M., Cilla G., Perez-Yarza E.G., Perez-Trallero E., Differences in clinical severity between genotype A and genotype B human metapneumovirus infection in children, Clin. Infect. Dis. (2006) 42:e111-e113.
22. Wathen M.W., Kakuk T.J., Brideau R.J., Hausknecht E.C., Cole S.L., Zaya R.M., Vaccination of cotton rats with a chimeric FG glycoprotein of human respiratory syncytial virus induces minimal pulmonary pathology on challenge, J. Infect. Dis. (1991) 163:477-482.
23. Williams J.V., Tollefson S.J., Johnson J.E., Crowe J.E. Jr., The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity, J. Virol. (2005) 79:10944-10951.
24. Williams J.V., Tollefson S.J., Heymann P.W., Carper H.T., Patrie J., Crowe J.E., Human metapneumovirus infection in children hospitalized for wheezing, J. Allergy Clin. Immunol. (2005) 115:1311-1312.
25. Wilkesmann A., Schildgen O., Eis-Hubinger A.M., Geikowski T., Glatzel T., Lentze M.J., Bode U., Simon A., Human metapneumovirus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections, Eur. J. Pediatr. (2006) 165:467-475.
26. Wyde P.R., Chetty S.N., Timmerman P., Gilbert B.E., Andries K., Short duration aerosols of JNJ 2408068 (R170591) administered prophylactically or therapeutically protect cotton rats from experimental respiratory syncytial virus infection, Antiviral Res. (2003) 60:221-231.
27. Wyde P.R., Chetty S.N., Jewell A.M., Schoonover S.L., Piedra P.A., Development of a cotton rat-human metapneumovirus (HMPV) model for identifying and evaluating potential HMPV antivirals and vaccines, Antiviral Res. (2005) 66:57-66.